Mevalonic acid
Mevalonic acid is a lipid of Fatty Acyls (FA) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 10134 references associated with Mevalonic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for Mevalonic acid
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Mevalonic acid
PubChem Biomolecular Interactions and Pathways
NCBI Entrez Crosslinks
All references with Mevalonic acid
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Suri S et al. | Nitrogen-containing bisphosphonates induce apoptosis of Caco-2 cells in vitro by inhibiting the mevalonate pathway: a model of bisphosphonate-induced gastrointestinal toxicity. | 2001 | Bone | pmid:11595616 |
| van Beek E et al. | Independent pathways in the modulation of osteoclastic resorption by intermediates of the mevalonate biosynthetic pathway: the role of the retinoic acid receptor. | 2006 | Bone | pmid:16165408 |
| Taylor GW et al. | Excursions in biomedical mass spectrometry. | 1996 | Br J Clin Pharmacol | pmid:8807152 |
| Martin PD et al. | Pharmacodynamic effects and pharmacokinetics of a new HMG-CoA reductase inhibitor, rosuvastatin, after morning or evening administration in healthy volunteers. | 2002 | Br J Clin Pharmacol | pmid:12445025 |
| Mikulski SM et al. | Synergism between a novel amphibian oocyte ribonuclease and lovastatin in inducing cytostatic and cytotoxic effects in human lung and pancreatic carcinoma cell lines. | 1992 | Br. J. Cancer | pmid:1503903 |
| Kawata S et al. | Modulation of the mevalonate pathway and cell growth by pravastatin and d-limonene in a human hepatoma cell line (Hep G2). | 1994 | Br. J. Cancer | pmid:8198962 |
| Jiang P et al. | In vitro and in vivo anticancer effects of mevalonate pathway modulation on human cancer cells. | 2014 | Br. J. Cancer | pmid:25093497 |
| Bocci G et al. | Fluvastatin synergistically enhances the antiproliferative effect of gemcitabine in human pancreatic cancer MIAPaCa-2 cells. | 2005 | Br. J. Cancer | pmid:16052215 |
| Jagdev SP et al. | The bisphosphonate, zoledronic acid, induces apoptosis of breast cancer cells: evidence for synergy with paclitaxel. | 2001 | Br. J. Cancer | pmid:11308265 |
| Prottey C et al. | Lipid synthesis in rat skin. | 1972 | Br. J. Dermatol. | pmid:4648803 |
| Lin Y et al. | Differences in propionate-induced inhibition of cholesterol and triacylglycerol synthesis between human and rat hepatocytes in primary culture. | 1995 | Br. J. Nutr. | pmid:7547837 |
| Eberlein M et al. | Rho-dependent inhibition of the induction of connective tissue growth factor (CTGF) by HMG CoA reductase inhibitors (statins). | 2001 | Br. J. Pharmacol. | pmid:11487529 |
| Stalker TJ et al. | A new HMG-CoA reductase inhibitor, rosuvastatin, exerts anti-inflammatory effects on the microvascular endothelium: the role of mevalonic acid. | 2001 | Br. J. Pharmacol. | pmid:11375257 |
| Takemoto M et al. | NK-104, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, reduces osteopontin expression by rat aortic smooth muscle cells. | 2001 | Br. J. Pharmacol. | pmid:11325797 |
| Hausding M et al. | Inhibition of small G proteins of the rho family by statins or clostridium difficile toxin B enhances cytokine-mediated induction of NO synthase II. | 2000 | Br. J. Pharmacol. | pmid:11015307 |
| Luo JD et al. | Simvastatin inhibits noradrenaline-induced hypertrophy of cultured neonatal rat cardiomyocytes. | 2001 | Br. J. Pharmacol. | pmid:11156573 |
| Goto S et al. | Species specificity in the blood cholesterol-lowering effect of YM-16638. | 1996 | Br. J. Pharmacol. | pmid:8733592 |
| Igarashi J et al. | Statins induce S1P1 receptors and enhance endothelial nitric oxide production in response to high-density lipoproteins. | 2007 | Br. J. Pharmacol. | pmid:17220911 |
| Minichsdorfer C and Hohenegger M | Autocrine amplification loop in statin-induced apoptosis of human melanoma cells. | 2009 | Br. J. Pharmacol. | pmid:19563533 |
| Alvarez De Sotomayor M et al. | Characterization of endothelial factors involved in the vasodilatory effect of simvastatin in aorta and small mesenteric artery of the rat. | 2000 | Br. J. Pharmacol. | pmid:11082126 |
| Werner M et al. | Mutual amplification of apoptosis by statin-induced mitochondrial stress and doxorubicin toxicity in human rhabdomyosarcoma cells. | 2004 | Br. J. Pharmacol. | pmid:15289292 |
| Naidu A et al. | Secretion of apolipoprotein E by brain glia requires protein prenylation and is suppressed by statins. | 2002 | Brain Res. | pmid:12468034 |
| Mellon SH and Deschepper CF | Neurosteroid biosynthesis: genes for adrenal steroidogenic enzymes are expressed in the brain. | 1993 | Brain Res. | pmid:8111631 |
| Klawitter J et al. | Effects of lovastatin on breast cancer cells: a proteo-metabonomic study. | 2010 | Breast Cancer Res. | pmid:20205716 |
| Ural AU et al. | In vitro synergistic cytoreductive effects of zoledronic acid and radiation on breast cancer cells. | 2006 | Breast Cancer Res. | pmid:16925824 |
| Rachner TD et al. | Dickkopf-1 is regulated by the mevalonate pathway in breast cancer. | 2014 | Breast Cancer Res. | pmid:24528599 |
| Journe F et al. | Farnesol, a mevalonate pathway intermediate, stimulates MCF-7 breast cancer cell growth through farnesoid-X-receptor-mediated estrogen receptor activation. | 2008 | Breast Cancer Res. Treat. | pmid:17333335 |
| Schwartz YSh et al. | Cholesterol-induced stimulation of postinflammatory liver fibrosis. | 2008 | Bull. Exp. Biol. Med. | pmid:19110552 |
| Alla S et al. | [Mevalonolactone: a volatile compound produced by Psammotettix alienus (Dhb)]. | 2002 | C. R. Biol. | pmid:12481687 |
| Cheng G et al. | Mitochondria-targeted nitroxides exacerbate fluvastatin-mediated cytostatic and cytotoxic effects in breast cancer cells. | 2011 | Cancer Biol. Ther. | pmid:21799303 |
| Duncan RE et al. | Statins and cancer development. | 2005 | Cancer Epidemiol. Biomarkers Prev. | pmid:16103434 |
| Karlic H et al. | Inhibition of the mevalonate pathway affects epigenetic regulation in cancer cells. | 2015 | Cancer Genet | pmid:25978957 |
| Girgert R et al. | Growth inhibition of neuroblastoma cells by lovastatin and L-ascorbic acid is based on different mechanisms. | 1999 | Cancer Lett. | pmid:10374838 |
| Tuerdi G et al. | Synergistic effect of combined treatment with gamma-tocotrienol and statin on human malignant mesothelioma cells. | 2013 | Cancer Lett. | pmid:23879968 |
| Gopalan A et al. | Simvastatin inhibition of mevalonate pathway induces apoptosis in human breast cancer cells via activation of JNK/CHOP/DR5 signaling pathway. | 2013 | Cancer Lett. | pmid:22960596 |
| Gopalan A et al. | Eliminating drug resistant breast cancer stem-like cells with combination of simvastatin and gamma-tocotrienol. | 2013 | Cancer Lett. | pmid:23063651 |
| Nilsson S et al. | Mevalonate pathway inhibitors affect anticancer drug-induced cell death and DNA damage response of human sarcoma cells. | 2011 | Cancer Lett. | pmid:21356574 |
| Ren Z and Gould MN | Inhibition of ubiquinone and cholesterol synthesis by the monoterpene perillyl alcohol. | 1994 | Cancer Lett. | pmid:8149348 |
| Nakajima H et al. | Induction of mitochondria-dependent apoptosis through the inhibition of mevalonate pathway in human breast cancer cells by YM529, a new third generation bisphosphonate. | 2007 | Cancer Lett. | pmid:17316980 |
| Grigor MR et al. | Cholesterol metabolism in rats bearing Morris hepatoma 7777. | 1973 | Cancer Res. | pmid:4352741 |
| Virtanen SS et al. | Alendronate inhibits invasion of PC-3 prostate cancer cells by affecting the mevalonate pathway. | 2002 | Cancer Res. | pmid:11980672 |
| Zaidi N et al. | ATP-citrate lyase: a key player in cancer metabolism. | 2012 | Cancer Res. | pmid:22787121 |
| Schulz S et al. | Mechanisms of cell growth inhibition and cell cycle arrest in human colonic adenocarcinoma cells by dehydroepiandrosterone: role of isoprenoid biosynthesis. | 1992 | Cancer Res. | pmid:1531325 |
| Larsson O and Johansson BM | Mevalonic acid products as mediators of cell proliferation in simian virus 40-transformed 3T3 cells. | 1987 | Cancer Res. | pmid:3040232 |
| George R and Goldfarb S | Inhibition of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in Morris hepatoma 7800 after intravenous injection of mevalonic acid. | 1980 | Cancer Res. | pmid:7438103 |
| Shipman CM et al. | The bisphosphonate incadronate (YM175) causes apoptosis of human myeloma cells in vitro by inhibiting the mevalonate pathway. | 1998 | Cancer Res. | pmid:9850051 |
| Eggens I et al. | Cytidine 5'-triphosphate-dependent dolichol kinase and dolichol phosphatase activities and levels of dolichyl phosphate in microsomal fractions from highly differentiated human hepatomas. | 1988 | Cancer Res. | pmid:2836054 |
| Schulz S and Nyce JW | Inhibition of protein isoprenylation and p21ras membrane association by dehydroepiandrosterone in human colonic adenocarcinoma cells in vitro. | 1991 | Cancer Res. | pmid:1835900 |
| Bricker LA et al. | Effects of dietary cholesterol on bile acid synthesis in liver and hepatomas. | 1974 | Cancer Res. | pmid:4359874 |
| Kandutsch AA and Hancock RL | Regulation of the rate of sterol synthesis and the level of beta-hydroxy-beta-methylglutaryl coenzyme A reductase activity in mouse liver and hepatomas. | 1971 | Cancer Res. | pmid:4328734 |
| Pandyra A et al. | Immediate utility of two approved agents to target both the metabolic mevalonate pathway and its restorative feedback loop. | 2014 | Cancer Res. | pmid:24994712 |
| Goldfarb S and Pitot HC | The regulation of beta-hydroxy-beta-methylglutaryl coenzyme A reductase in Morris hepatomas 5123C, 7800, and 9618A. | 1971 | Cancer Res. | pmid:4330433 |
| Cuthbert JA and Lipsky PE | Regulation of proliferation and Ras localization in transformed cells by products of mevalonate metabolism. | 1997 | Cancer Res. | pmid:9270019 |
| El-Sohemy A and Archer MC | Regulation of mevalonate synthesis in rat mammary glands by dietary n-3 and n-6 polyunsaturated fatty acids. | 1997 | Cancer Res. | pmid:9288773 |
| Kotamraju S et al. | Statin-induced breast cancer cell death: role of inducible nitric oxide and arginase-dependent pathways. | 2007 | Cancer Res. | pmid:17671209 |
| Cuthbert JA and Lipsky PE | Suppression of the proliferation of Ras-transformed cells by fluoromevalonate, an inhibitor of mevalonate metabolism. | 1995 | Cancer Res. | pmid:7712482 |
| Larsson O et al. | Abolition of mevinolin-induced growth inhibition in human fibroblasts following transformation by simian virus 40. | 1989 | Cancer Res. | pmid:2551491 |
| TERNER C and KORSH G | THE BIOSYNTHESIS OF GLYCERIDES IN HOMOGENATES OF NORMAL LACTATING MAMMARY GLAND AND OF MAMMARY TUMOR TISSUE OF THE MOUSE. | 1963 | Cancer Res. | pmid:14079150 |
| Girlanda S et al. | MICA expressed by multiple myeloma and monoclonal gammopathy of undetermined significance plasma cells Costimulates pamidronate-activated gammadelta lymphocytes. | 2005 | Cancer Res. | pmid:16103105 |
| Komori A et al. | Canventol inhibits tumor promotion in CD-1 mouse skin through inhibition of tumor necrosis factor alpha release and of protein isoprenylation. | 1993 | Cancer Res. | pmid:8339247 |
| Shoff SM et al. | Concentration-dependent increase of murine P388 and B16 population doubling time by the acyclic monoterpene geraniol. | 1991 | Cancer Res. | pmid:1988098 |
| Andela VB | Correspondence Re S. S. Virtanen et al., Alendronate inhibits invasion of PC-3 prostate cancer cells by affecting the mevalonate pathway. Cancer Res 2002;62:2708-14. Re K. Sawada et al., Alendronate inhibits lysophosphatidic acid-induced migration of human ovarian cancer cells by attenuating the activation of Rho. Cancer Res 2002;62:6015-20. | 2004 | Cancer Res. | pmid:15087415 |
| Humphries GM | Difference in the ability of compactin and oxidized cholesterol, both known inhibitors of cholesterol biosynthesis, to suppress in vitro immune responses. | 1981 | Cancer Res. | pmid:7260948 |
| Dalton MB et al. | The farnesyl protein transferase inhibitor BZA-5B blocks farnesylation of nuclear lamins and p21ras but does not affect their function or localization. | 1995 | Cancer Res. | pmid:7614464 |
| Soma MR et al. | In vivo enhanced antitumor activity of carmustine [N,N'-bis(2-chloroethyl)-N-nitrosourea] by simvastatin. | 1995 | Cancer Res. | pmid:7834630 |
| Takeda I et al. | Simvastatin inactivates beta1-integrin and extracellular signal-related kinase signaling and inhibits cell proliferation in head and neck squamous cell carcinoma cells. | 2007 | Cancer Sci. | pmid:17428261 |
| Palozza P et al. | Lycopene induces cell growth inhibition by altering mevalonate pathway and Ras signaling in cancer cell lines. | 2010 | Carcinogenesis | pmid:20699249 |
| Nawarskas JJ | HMG-CoA reductase inhibitors and coenzyme Q10. | 2005 Mar-Apr | Cardiol Rev | pmid:15705257 |
| Liang YJ et al. | Simvastatin inhibits C-reactive protein-induced pro-inflammatory changes in endothelial cells by decreasing mevalonate pathway products. | 2008 | Cardiology | pmid:18057884 |
| Szűcs G et al. | Cardioprotection by farnesol: role of the mevalonate pathway. | 2013 | Cardiovasc Drugs Ther | pmid:23673412 |
| Guo H et al. | Rosuvastatin may modulate insulin signaling and inhibit atherogenesis beyond its plasma cholesterol-lowering effect in insulin-resistant mice. | 2012 | Cardiovasc Drugs Ther | pmid:22918601 |
| Massaro M et al. | Statins inhibit cyclooxygenase-2 and matrix metalloproteinase-9 in human endothelial cells: anti-angiogenic actions possibly contributing to plaque stability. | 2010 | Cardiovasc. Res. | pmid:19946014 |
| Kojima Y et al. | Pitavastatin decreases the expression of endothelial lipase both in vitro and in vivo. | 2010 | Cardiovasc. Res. | pmid:20045866 |
| Jeon JG et al. | Natural products in caries research: current (limited) knowledge, challenges and future perspective. | 2011 | Caries Res. | pmid:21576957 |
| Freed-Pastor WA et al. | Mutant p53 disrupts mammary tissue architecture via the mevalonate pathway. | 2012 | Cell | pmid:22265415 |
| Okin D and Medzhitov R | The Effect of Sustained Inflammation on Hepatic Mevalonate Pathway Results in Hyperglycemia. | 2016 | Cell | pmid:26997483 |
| York AG et al. | Limiting Cholesterol Biosynthetic Flux Spontaneously Engages Type I IFN Signaling. | 2015 | Cell | pmid:26686653 |
| Weber C et al. | Lovastatin induces differentiation of Mono Mac 6 cells. | 1995 | Cell Biochem. Funct. | pmid:8565148 |
| Bacurau RF et al. | Metabolic response of macrophages to injury promoted by the activated complement system. | 1999 | Cell Biochem. Funct. | pmid:10451538 |
| Senkowski W et al. | Large-Scale Gene Expression Profiling Platform for Identification of Context-Dependent Drug Responses in Multicellular Tumor Spheroids. | 2016 | Cell Chem Biol | pmid:27984028 |
| Ginestier C et al. | p53 and cancer stem cells: the mevalonate connexion. | 2012 | Cell Cycle | pmid:22751434 |
| Agabiti SS et al. | Geranylgeranyl diphosphate synthase inhibition induces apoptosis that is dependent upon GGPP depletion, ERK phosphorylation and caspase activation. | 2017 | Cell Death Dis | pmid:28300835 |
| Qi XF et al. | HMG-CoA reductase inhibitors induce apoptosis of lymphoma cells by promoting ROS generation and regulating Akt, Erk and p38 signals via suppression of mevalonate pathway. | 2013 | Cell Death Dis | pmid:23449454 |
| Laezza C et al. | p53 regulates the mevalonate pathway in human glioblastoma multiforme. | 2015 | Cell Death Dis | pmid:26469958 |
| Bruzzese F et al. | Panobinostat synergizes with zoledronic acid in prostate cancer and multiple myeloma models by increasing ROS and modulating mevalonate and p38-MAPK pathways. | 2013 | Cell Death Dis | pmid:24157872 |
| Zhu Y et al. | Deciphering the signaling networks underlying simvastatin-induced apoptosis in human cancer cells: evidence for non-canonical activation of RhoA and Rac1 GTPases. | 2013 | Cell Death Dis | pmid:23559002 |
| Ghavami S et al. | Apoptosis, autophagy and ER stress in mevalonate cascade inhibition-induced cell death of human atrial fibroblasts. | 2012 | Cell Death Dis | pmid:22717585 |
| Khosravi-Far R et al. | Protein prenylation: key to ras function and cancer intervention? | 1992 | Cell Growth Differ. | pmid:1419908 |
| Miettinen TP and Björklund M | Mevalonate Pathway Regulates Cell Size Homeostasis and Proteostasis through Autophagy. | 2015 | Cell Rep | pmid:26686643 |
| Takii Y et al. | Arrest of 3T3 cells in G1 phase by low density lipoprotein. | 1983 | Cell Struct. Funct. | pmid:6671216 |
| Yachnin S and Hsu R | Inhibition of human lymphocyte transformation by oxygenated sterol compounds. | 1980 | Cell. Immunol. | pmid:7363333 |
| Jameson JM et al. | A role for the mevalonate pathway in the induction of subtype cross-reactive immunity to influenza A virus by human gammadelta T lymphocytes. | 2010 | Cell. Immunol. | pmid:20483407 |
| Bank I et al. | Lovastatin and phospholipase Cgamma regulate constitutive and protein kinase C dependent integrin mediated interactions of human T-cells with collagen. | 2003 | Cell. Immunol. | pmid:12914756 |
| Larson RA et al. | Neutrophil-assisted DNA synthesis by human lymphocytes in response to mevalonic acid; enhancement by cytochalasin B. | 1983 | Cell. Immunol. | pmid:6640672 |
| Yu F et al. | Zingiber zerumbet CYP71BA1 catalyzes the conversion of α-humulene to 8-hydroxy-α-humulene in zerumbone biosynthesis. | 2011 | Cell. Mol. Life Sci. | pmid:20730551 |
| Houten SM et al. | Isoprenoid biosynthesis in hereditary periodic fever syndromes and inflammation. | 2003 | Cell. Mol. Life Sci. | pmid:12861380 |
| Chen B et al. | Alteration of mevalonate pathway related enzyme expressions in pressure overload-induced cardiac hypertrophy and associated heart failure with preserved ejection fraction. | 2013 | Cell. Physiol. Biochem. | pmid:24356578 |
| Ropero S et al. | Cholesterol cell content modulates GTPase activity of G proteins in GH4C1 cell membranes. | 2003 | Cell. Signal. | pmid:12401528 |
| Valente AJ et al. | Interleukin-18 enhances IL-18R/Nox1 binding, and mediates TRAF3IP2-dependent smooth muscle cell migration. Inhibition by simvastatin. | 2013 | Cell. Signal. | pmid:23541442 |
| Iguchi T et al. | Nitrogen-containing bisphosphonates induce S-phase cell cycle arrest and apoptosis of myeloma cells by activating MAPK pathway and inhibiting mevalonate pathway. | 2003 | Cell. Signal. | pmid:12742232 |